-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$80.9242.82% Upside
Recent Analyst Forecasts and Stock Ratings
Cytokinetics, Incorporated Frequently Asked Questions
-
What analysts cover Cytokinetics, Incorporated?
Cytokinetics, Incorporated has been rated by research analysts at Goldman Sachs, Piper Sandler, B.Riley Financial, JMP Securities, H.C. Wainwright, Needham in the past 90 days.